Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study
- Resource Type
- Article
- Authors
- Bekaii-Saab, Tanios S; Ou, Fang-Shu; Ahn, Daniel H; Boland, Patrick M; Ciombor, Kristen K; Heying, Erica N; Dockter, Travis J; Jacobs, Nisha L; Pasche, Boris C; Cleary, James M; Meyers, Jeffrey P; Desnoyers, Rodwige J; McCune, Jeannine S; Pedersen, Katrina; Barzi, Afsaneh; Chiorean, E Gabriela; Sloan, Jeffrey; Lacouture, Mario E; Lenz, Heinz-Josef; Grothey, Axel
- Source
- In The Lancet Oncology August 2019 20(8):1070-1082
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045